methide moiety is not formed by dehydration during PKS
assembly and the IMDA cycloaddition takes place at a later
stage of polyketide assembly, open-chain seco acid 6 (allyl
benzyl alcohol) and—with respect to the gene analysis more
likely—allyl alcohol 7 can be envisaged as possible open-
chain precursors (cases 1a and 1b in Scheme 4). At this stage
the vinylogous quinone methide 8, the key intermediate of
this biosynthetic sequence, is generated which would directly
undergo IMDA cycloaddition to give tetrahydroindane
quinone methide 5 (elansolid A3). In a tandem fashion, this
highly reactive species would cyclize by a Michael-type attack
of the carboxylate onto the quinone methide moiety. As a
result elansolid A 1 is formed. If water, methanol, or ammonia
serve as nucleophiles, elansolids B1–B3 (2–4) are generated,
instead.
In principle it cannot be excluded that IMDA substrate 8
originates from either the 24-membered macolactone 9 or
alternatively the 26-membered macolactone 10 after lactone
activation (cases 2a and 2b; Scheme 1). Intermediate 9 is
clearly favored over 10 by the proposed biosynthetic outlined
above. This scenario would require a PKS-associated cyclizing
thioesterase (TE) instead of the hydrolyzing TE as shown in
Scheme 2. Bioinformatic analysis currently does not allow a
distinction between TEs that preferentially hydrolyze or
lactonize. Importantly, in both cases 1 and 2 presented in
Scheme 4 the Diels–Alder cycloaddition generates elanso-
lid A3 (5) which would then directly cyclize through a
Michael-type addition of the carboxylate onto the quinone
methide moiety and result in elansolid A (1).
Based on the feeding experiments and the principal
considerations mentioned above we consequently addressed
the question of the IMDA cycloaddition[10] by preparing the
synthetic model compound all-E triene 11 (resembling IMDA
precursors 6 and 10) and the simplified regioisomer 12
(resembling precursors 7 and 9). It must be noted that model
substrate 11 was designed first to be closely related to the
natural system in order to study all factors of diastereocontrol
during IMDA cycloaddition in more detail.[11] The E config-
uration of all olefinic double bonds would result in the correct
relative configuration at C16, C19, C23, and C24[12] via the two
possible endo transition states TS-I and TS-II. The stereo-
center at position 20 has to exert diastereofacial control.[13]
The synthesis of allyl alcohol 22 commenced with allyl
chloride 18[14] which was transformed into allyl alcohol 19 by a
standard sequence that included a-allylation of 17, reduction/
oxidation followed by Horner–Wadsworth–Emmons (HWE)
olefination with phosphonate 13, ester reduction, O-silylation
of the intermediate allyl alcohol, and finally PMB removal
(Scheme 5). The methylidene moiety in 19 was epoxidized
under Sharpless conditions with good enantiomeric excess
and the epoxy alcohol was then reductively ring-opened to
yield a 1,2-diol.[15] Formation of the cyclic PMB acetal and
cleavage under reductive conditions gave alcohol 20. Oxida-
tion furnished an aldehyde which was fused with phosphonate
16 by a HWE olefination, and the resulting alkyne 21 was
finally desilylated to afford allyl alcohol 22. Phosphonate 16[16]
was prepared from vinyl iodide 15 (from 14[17]) which was first
elaborated by a Sonogashira–Hagihara alkynylation followed
by Appel bromination and Michaelis–Arbusov reaction.
Scheme 5. Synthesis of allyl alcohol 22 and IMDA studies. Reagents
and conditions: a) 1. [Cp2ZrCl2], AlMe3, CH2Cl2, RT, 15 h, 2. I2, 50%;
b) Me3SiCCH, [Pd(PPh3)4], CuI, pyrrolidine, RT, 2 h, 80%; c) CBr4,
PPh3, CH2Cl2, RT, 30 min; d) P(OEt)3, microwave irradiation, 1008C,
30 min, 70% for two steps; e) 1. DIPA, nBuLi, THF, ꢀ788C to 08C,
then addition of 17, ꢀ788C!ꢀ408C, 2. addition of 18, TBAI, ꢀ408C
to RT, 82%; f) Dibal-H, THF, ꢀ788C!RT, 99%; g) PCC, CH2Cl2, RT;
h) NaH, (EtO)2P(O)CH2CO2Et (13), THF, 508C, then addition of
aldehyde (from g), 808C, 91% for two steps; i) 1. Dibal-H, THF,
ꢀ788C!RT, 2. TBSCl, imidazole, DMAP, CH2Cl2, RT, 99% for two
steps; j) DDQ, CH2Cl2, pH 7 phosphate buffer, RT, 93%; k) Ti(OiPr)4,
d-(ꢀ)-DET, tBuOOH, CH2Cl2, ꢀ258C, 93%, 95% ee (determined by
1H NMR spectroscopy after formation of the S Mosher ester[15]);
l) LiAlH4, THF, 08C to RT, 86%; m) 1. 4-MeO-C6H4-CH(OMe)2, PPTS,
CH2Cl2, RT, 2. Dibal-H, toluene, ꢀ788C!RT, 89% for two steps;
n) DMP, NaHCO3, CH2Cl2, 08C, 86%; o) NaHMDS, 16, THF, ꢀ788C,
then addition of aldehyde, ꢀ788C!RT, 84%, all-E/other iso-
mers=10:1; p) TBAF, THF, 08C to RT, 99%; q) 1. TPAP, NMO,
ꢀ
CH2Cl2, ꢀ308C; 2. RC6H4 MgBr, THF, TMEDA, ꢀ788C to ꢀ508C
(R=OMe, 75%; R=TMS, 81% for two steps); r) 24a,b, TPAP, NMO,
MS 4 ꢃ, CH2Cl2, ꢀ308C (67%; de=5:1). Compounds 25 were not
obtained. Abbreviations: Cp=cyclopentadienyl, DIPA=ethyldiisopro-
pylamine, TBAI=tetra-n-butylammonium iodide, Dibal-H=diisobutyl-
aluminum hydride, PCC=pyridinium chlorochromate, TBS=tert-butyl-
dimethylsilyl, DMAP=4-dimethylaminopyridine, DDQ=dichlorodicya-
noquinone, DET=diethyl tartrate, PPTS=pyridinium p-toluenesulfo-
nate, DMP=Dess–Martin periodinane, NaHMDS=sodium hexame-
thyldisilazide, TBAF=tetra-n-butylammonium fluoride, TPAP=tetra-n-
propylammonium perruthenate, NMO=N-methylmorpholine N-oxide.
Using the Ley–Griffith method[18] we next oxidized allyl
alcohol 22 at ꢀ308C to the corresponding aldehyde which was
treated directly with 4-methoxyphenylmagnesium bromide or
alternatively with 4-trimethylsilylphenylmagnesium bro-
mide[19] to afford allyl benzyl alcohols 23a,b and 24a,b,
respectively, as mixture of diastereomers (ca. 1:1 for both
examples; Scheme 5). These alcohols served as model qui-
none methide precursors (see allyl benzyl alcohol 6,
Scheme 4). In no case were Brønstedt or Lewis acids able to
Angew. Chem. Int. Ed. 2011, 50, 3882 –3887
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3885